Table 2.

Comparison of admitting suPAR and KIM‐1 levels between COVID‐19 patients with moderate and severe disease and between patients and controls

	COVID‐19 severity		Control (mean ± SD) (n = 50)	*p/**p
	Moderate (mean ± SD) (n = 62)	Severe (mean ± SD) (n = 40)
suPAR (ng/ml)	8.4 ± 4.2	5.5 ± 3.1	1.3 ± 1.1	0.001/0.001
KIM‐1 (pg/ml)	84.5 ± 62.3	134.9 ± 66.5	34.6 ± 57.4	0.001/0.001

Note: *p = Comparison of moderate and severe patients, **p = Comparison of patients and controls.

Abbreviations: COVID‐19, coronavirus disease 2019; KIM‐1, kidney injury molecule‐1; suPAR, soluble urokinase plasminogen activator receptor.